Biochemistry (Moscow)

, Volume 82, Issue 5, pp 613–624 | Cite as

Two variants of recombinant human bone morphogenetic protein-2 (rhBMP-2) with additional protein domains: Synthesis in an Escherichia coli heterologous expression system

  • A. S. Karyagina
  • I. S. Boksha
  • T. M. Grunina
  • A. V. Demidenko
  • M. S. Poponova
  • O. V. Sergienko
  • A. M. Lyashchuk
  • Z. M. Galushkina
  • L. A. Soboleva
  • E. O. Osidak
  • M. S. Bartov
  • A. V. GromovEmail author
  • V. G. Lunin


Two variants of recombinant human bone morphogenetic protein-2 (rhBMP-2) with additional N-terminal protein domains were obtained by expression in E. coli. The N-terminal domains were s-tag (15-a.a. oligopeptide from bovine pancreatic ribonuclease A) and lz (leucine zipper dimerization domain from yeast transcription factor GCN4). The s-tag-BMP-2 and lz-BMP-2 were purified by a procedure that excluded a long refolding stage. The resulting dimeric proteins displayed higher solubility compared to rhBMP-2 without additional protein domains. Biological activity of both proteins was demonstrated in vitro by induction of alkaline phosphatase in C2C12 cells, and the activity of s-tag-BMP-2 in vivo was shown in various experimental animal models.


recombinant bone morphogenetic protein-2 heterologous expression Escherichia coli 



amino acid residue


2,2′-bicinchoninic acid


bone morphogenetic protein-2


human BMP-2


fragment of yeast GCN4 transcription factor corresponding to GCN4 leucine zipper dimerization domain


recombinant human BMP-2


15-a.a. fragment of bovine pancreatic ribonuclease A


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. (1988) Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528–1534.CrossRefPubMedGoogle Scholar
  2. 2.
    Israel, D. I., Nove, J., Kerns, K. M., Moutsatsos, I. K., and Kaufman, R. J. (1992) Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells, Growth Factors, 7, 139–150.CrossRefPubMedGoogle Scholar
  3. 3.
    Von Einem, S., Erler, S., Bigl, K., Frerich, B., and Schwarz, E. (2011) The proform of BMP-2 exhibits a delayed and reduced activity when compared to mature BMP-2, Growth Factors, 29, 63–71.CrossRefGoogle Scholar
  4. 4.
    Scheufler, C., Sebald, W., and Hulsmeyer, M. (1999) Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution, J. Mol. Biol., 287, 103–115.CrossRefPubMedGoogle Scholar
  5. 5.
    Zaitsev, V. V., Karyagina, A. S., and Lunin, V. G. (2009) Bone morphogenetic proteins (BMP): characteristics, prospects of clinical application in traumatology and orthopedics, Vestn. Travmatol. Ortoped. im. N. N. Priorova, 4, 79–84.Google Scholar
  6. 6.
    Allendorph, G. P., Vale, W. W., and Choe, S. (2006) Structure of the ternary signaling complex of a TGF-β superfamily member, Proc. Natl. Acad. Sci. USA, 103, 7643–7648.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Li, R. H., and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins, Trends Biotechnol., 19, 255–265.CrossRefPubMedGoogle Scholar
  8. 8.
    Kirker-Head, C. A. (2000) Potential applications and delivery strategies for bone morphogenetic proteins, Adv. Drug Deliv. Rev., 43, 65–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Wang, E. A., Rosen, V., D’Alessandro, J. S., Bauduy, M., Cordes, P., Harada, T., Israel, D. I., Hewick, R. M., Kerns, K. M., and LaPan, P. (1990) Recombinant human bone morphogenetic protein induces bone formation, Proc. Natl. Acad. Sci. USA, 87, 2220–2224.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ruppert, R., Hoffmann, E., and Sebald, W. (1996) Human bone morphogenetic protein 2 contains a heparinbinding site which modifies its biological activity, Eur. J. Biochem., 237, 295–302.CrossRefPubMedGoogle Scholar
  11. 11.
    Vallejo, L. F., Brokelmann, M., Marten, S., Trappe, S., Cabrera-Crespo, J., Hoffmann, A., Gross, G., Weich, H. A., and Rinas, U. (2002) Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in highcelldensity cultures of recombinant Escherichia coli, J. Biotechnol., 94, 185–194.CrossRefPubMedGoogle Scholar
  12. 12.
    Vallejo, L. F., and Rinas, U. (2004) Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration, Biotechnol. Bioeng., 85, 601–609.CrossRefPubMedGoogle Scholar
  13. 13.
    Boix, T., Gomez-Morales, J., Torrent-Burgues, J., Monfort, A., Puigdomenech, P., and Rodriguez-Clemente, R. (2005) Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite, J. Inorg. Biochem., 99, 1043–1050.CrossRefPubMedGoogle Scholar
  14. 14.
    Long, S., Truong, L., Bennett, K., Phillips, A., Wong-Staal, F., and Ma, H. (2006) Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli, Protein Expr. Purif., 46, 374–378.CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang, H., Wu, J., Zhang, Y., Fu, N., Wang, J., and Zhao, S. (2010) Optimized procedure for expression and renaturation of recombinant human bone morphogenetic protein-2 at high protein concentrations, Mol. Biol., 37, 3089–3095.Google Scholar
  16. 16.
    Von Einem, S., Schwarz, E., and Rudolph, R. (2010) A novel twostep renaturation procedure for efficient production of recombinant BMP-2, Protein Expr. Purif., 73, 65–69.CrossRefGoogle Scholar
  17. 17.
    Zhang, Y., Ma, Y., Yang, M., Min, S., Yao, J., and Zhu, L. (2011) Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro, Protein Expr. Purif., 75, 155–160.CrossRefPubMedGoogle Scholar
  18. 18.
    Karyagina, A. S., Boksha, I. S., Grunina, T., M., Demidenko, A. V., Poponova, M. S., Sergienko, O. V., Lyashchuk, A. M., Galushkina, Z. M., Soboleva, L. A., Osidak, E. O., Semikhin, A. S., Gromov, A. V., and Lunin, V. G. (2016) Optimization of rhBMP-2 activeform production in a heterologous expression system using microbiological and molecular genetic approaches, Mol. Genet. Microbiol. Virol., 31, 208–213.CrossRefGoogle Scholar
  19. 19.
    Raines, R. T., McCormick, M., Van Oosbree, T. R., and Mierendorf, R. C. (2000) The stag fusion system for protein purification, Methods Enzymol., 326, 362–376.CrossRefPubMedGoogle Scholar
  20. 20.
    Deiss, S., Alvarez, B. H., Bar, K., Ewers, C. P., Coles, M., Albrecht, R., and Hartmann, M. D. (2014) Your personalized protein structure: Andrei N. Lupas fused to GCN4 adaptors, J. Struct. Biol., 186, 380–385.CrossRefPubMedGoogle Scholar
  21. 21.
    Sambrook, J., Fritch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor.Google Scholar
  22. 22.
    Boksha, I. S., Lavrova, N. V., Grishin, A. V., Demidenko, A. V., Lyashchuk, A. M., Galushkina, Z. M., Ovchinnikov, R. S., Umyarov, A. M., Avetisian, L. R., Chernukha, M. Iu., Shaginian, I. A., Lunin, V. G., and Karyagina, A. S. (2016) Staphylococcus simulans recombinant lysostaphin: production, purification, and determination of antistaphylococcal activity, Biochemistry (Moscow), 81, 502–510.CrossRefGoogle Scholar
  23. 23.
    Gasparian, M. E., Ostapchenko, V. G., Schulga, A. A., Dolgikh, D. A., and Kirpichnikov, M. P. (2003) Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli, Protein Expr. Purif., 31, 133–139.CrossRefPubMedGoogle Scholar
  24. 24.
    Sharapova, N. E., Kotnova, A. P., Galushkina, Z. M., Lavrova, N. V., Poletaeva, N. N., Tukhvatulin, A. E., Semikhin, A. S., Gromov, A. V., Soboleva, L. A., Ershova, A. S., Zaitsev, V. V., Sergeenko, O. V., Lunin, V. G., and Karyagina, A. S. (2010) Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo, Mol. Biol. (Moscow), 44, 1036–1044.CrossRefGoogle Scholar
  25. 25.
    Chen, B., Lin, H., Wang, J., Zhao, Y., Wang, B., Zhao, W., Sun, W., and Dai, J. (2007) Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagentargeting bone morphogenetic protein-2, Biomaterials, 28, 1027–1035.CrossRefPubMedGoogle Scholar
  26. 26.
    Hwang, C. J., Vaccaro, A. R., Lawrence, J. P., Hong, J., Schellekens, H., Alaoui-Ismaili, M. H., and Falb, D. (2009) Immunogenicity of bone morphogenetic proteins, J. Neurosurg. Spine, 10, 443–451.CrossRefPubMedGoogle Scholar
  27. 27.
    Bartov, M. S., Gromov, A. V., Poponova, M. S., Savina, D. M., Nikitin, K. E., Grunina, T. M., Manskikh, V. N., Gra, O. A., Lunin, V. G., Karyagina, A. S., and Gintsburg, A. L. (2016) Modern approaches to studies of new osteogenic biomaterials on the model of regeneration of criticalsize cranial defects in rats, Bull. Exp. Biol. Med., 162, 273–276.CrossRefPubMedGoogle Scholar
  28. 28.
    Gaifullin, N. M., Karyagina, A. S., Gromov, A. V., Terpilovskiy, A.A., Malanin, D. A., Demeshchenko, M. V., and Novochadov, V. V. (2016) Morphological characteristics of osseointegration of titanium implants with bioactive coating and recombinant bone morphogenic protein, Morfologiya, 149, 77–84.Google Scholar
  29. 29.
    Chang, P.-C., Lang, N. P., and Giannobile, W. V. (2010) Evaluation of functional dynamics during osseointegration and regeneration associated with oral implants, Oral Implants Res., 21, 1–12.CrossRefGoogle Scholar
  30. 30.
    Andreev, A. Yu., Zakharov, V. D., Zairatyants, O. V., Borzenok, S. A., Khubetsova, M. Kh., Osidak, E. O., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Prospects for the use of bone growth factor as a component of collagen matrix for cornea strengthening (experimental study), Sovr. Tekhnol. Oftalmol., 4, 11–16.Google Scholar
  31. 31.
    Zakharov, V. D., Andreev, A. Yu., Zairatyants, O. V., Osidak, E. O., Borzenok, S. A., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Morphological changes in rabbit cornea caused by the bone and cartilage growth factor rhBMP-2 used as a component of intracorneal implant, Klin. Eksp. Morfol., 4, 36–42.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2017

Authors and Affiliations

  • A. S. Karyagina
    • 1
    • 2
    • 3
  • I. S. Boksha
    • 1
    • 4
  • T. M. Grunina
    • 1
  • A. V. Demidenko
    • 1
  • M. S. Poponova
    • 1
  • O. V. Sergienko
    • 1
    • 3
  • A. M. Lyashchuk
    • 1
  • Z. M. Galushkina
    • 1
  • L. A. Soboleva
    • 1
  • E. O. Osidak
    • 5
  • M. S. Bartov
    • 1
  • A. V. Gromov
    • 1
    Email author
  • V. G. Lunin
    • 1
    • 3
  1. 1.Gamaleya Center of Epidemiology and MicrobiologyMinistry of Health of the Russian FederationMoscowRussia
  2. 2.Belozersky Institute of Physico-Chemical BiologyLomonosov Moscow State UniversityMoscowRussia
  3. 3.Russian Research Institute of Agricultural BiotechnologyMoscowRussia
  4. 4.Mental Health Research CenterMoscowRussia
  5. 5.IMTEK Ltd.MoscowRussia

Personalised recommendations